BRIDGEWAY CAPITAL MANAGEMENT, LLC - IN8BIO INC ownership

IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 16 filers reported holding IN8BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of IN8BIO INC
ValueSharesWeighting
Q3 2023$81,434
+7.9%
78,302
+59.8%
0.00%0.0%
Q2 2023$75,460
-21.6%
49,000
-33.8%
0.00%
-33.3%
Q1 2023$96,200
-43.7%
74,0000.0%0.00%
-25.0%
Q4 2022$170,940
+14.7%
74,0000.0%0.00%0.0%
Q3 2022$149,000
+2.1%
74,000
+23.3%
0.00%
+33.3%
Q2 2022$146,000
-29.8%
60,0000.0%0.00%
-25.0%
Q1 2022$208,00060,0000.00%
Other shareholders
IN8BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Voss Capital, LLC 511,584$532,0480.07%
Rock Creek Group, LP 151,314$157,3670.02%
Sigma Planning Corp 285,050$296,4520.01%
Overbrook Management Corp 33,756$35,1060.01%
Stonegate Investment Group, LLC 180,000$187,2000.01%
Texas Capital Bank Wealth Management Services Inc 42,445$44,1430.01%
Westside Investment Management, Inc. 14,500$15,0800.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 78,302$81,4340.00%
Ensign Peak Advisors, Inc 470,028$488,8290.00%
GEODE CAPITAL MANAGEMENT, LLC 188,849$196,4600.00%
View complete list of IN8BIO INC shareholders